NDAORALTABLET2 Generics Approved
Approved
Mar 2008
Lifecycle
LOE Approaching
Competitive Pressure
60/100
Clinical Trials
2
Data completeness
2/8 — Basic
Drug data last refreshed 11h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Morphine sulfate is an oral opioid analgesic tablet approved in 2008 for pain management. It is a mu-opioid receptor agonist that binds to opioid receptors in the central and peripheral nervous system to reduce pain perception. This product serves patients requiring moderate-to-severe pain relief across multiple therapeutic contexts.
LOE Approaching
Product is in LOE-approaching phase with moderate competitive pressure (60/100), signaling potential team downsizing or transition to generics support roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo
Started Aug 2010
33 enrolled
Narcotic AbuseOpioid-related DisordersAnalgesia+1 more
Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)
Started Mar 2007
32 enrolled
Healthy
Career Relevance
This morphine sulfate product offers limited growth-stage career opportunities given its LOE-approaching lifecycle and minimal linked job postings. Career value lies in operational, regulatory, and supply chain functions focused on generic transition and cost-efficient manufacturing rather than branded commercialization.
Worked on MORPHINE SULFATE at Hikma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.